Cytek Biosciences, Inc. - Laporan Laba Rugi (TTM)

Cytek Biosciences, Inc.
US ˙ NasdaqGS ˙ US23285D1090

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Cytek Biosciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 93 99 110 120 128 139 148 155 164 166 176 183 193 201 198 201 200 197 196
Change (%) 6.77 11.37 8.41 6.91 8.43 7.03 4.11 6.11 1.23 5.74 4.28 5.40 4.03 -1.53 1.77 -0.38 -1.70 -0.52
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 41 41 41 45 49 54 59 59 63 64 70 77 84 89 89 91 89 89 89
Change (%) 0.42 -0.49 8.81 9.14 10.45 9.15 0.88 6.24 1.84 9.24 10.27 8.04 6.94 -0.39 1.88 -1.50 -0.61 0.62
% of Revenue 44.30 41.67 37.23 37.37 38.14 38.85 39.63 38.40 38.44 38.68 39.95 42.25 43.31 44.52 45.03 45.08 44.57 45.06 45.58
Gross Operating Profit 52 58 69 75 79 85 90 95 101 102 105 106 109 111 109 111 111 108 107
Change (%) 11.82 19.85 8.17 5.59 7.19 5.68 6.23 6.03 0.85 3.54 0.30 3.47 1.80 -2.45 1.68 0.55 -2.57 -1.45
% of Revenue 55.70 58.33 62.77 62.63 61.86 61.15 60.37 61.60 61.56 61.32 60.05 57.75 56.69 55.48 54.97 54.92 55.43 54.94 54.42
SG&A 24 27 31 37 46 52 59 63 68 77 85 90 93 94 93 92 95 96 98
Change (%) 8.99 15.70 22.05 21.49 13.22 14.11 7.73 7.15 12.83 10.62 6.57 3.07 0.78 -1.27 -0.60 2.96 1.54 1.77
% of Revenue 26.24 26.78 27.82 31.33 35.60 37.17 39.62 41.00 41.41 46.15 48.28 49.34 48.24 46.74 46.86 45.77 47.31 48.86 49.98
R&D 14 16 19 22 24 27 30 32 35 37 41 43 44 44 42 41 39 39 38
Change (%) 15.18 20.78 14.18 12.37 11.99 8.19 8.68 8.30 5.59 10.05 6.23 2.61 -0.40 -4.86 -3.08 -2.83 -0.18 -2.99
% of Revenue 14.75 15.91 17.26 18.18 19.10 19.73 19.94 20.82 21.25 22.16 23.07 23.50 22.87 21.90 21.16 20.15 19.66 19.96 19.46
OpEx 79 84 91 104 119 133 147 155 166 178 195 211 221 227 224 223 224 224 225
Change (%) 5.61 8.66 14.41 14.27 11.83 10.88 5.19 7.04 7.13 10.00 7.83 4.80 2.87 -1.62 -0.08 0.10 0.37 0.48
% of Revenue 85.29 84.36 82.31 86.87 92.84 95.75 99.19 100.22 101.10 106.99 111.30 115.09 114.43 113.16 113.06 111.01 111.54 113.89 115.03
Operating Income 14 16 20 16 9 6 1 -0 -2 -12 -20 -28 -28 -26 -26 -22 -23 -27 -29
Change (%) 13.49 25.99 -19.53 -41.73 -35.59 -79.72 -128.51 429.03 543.51 70.94 39.20 0.80 -5.13 -2.28 -14.22 4.41 18.34 7.66
% of Revenue 14.71 15.64 17.69 13.13 7.16 4.25 0.81 -0.22 -1.10 -6.99 -11.30 -15.09 -14.43 -13.16 -13.06 -11.01 -11.54 -13.89 -15.03
Interest Expense -0 -1 -1 -2 -2 -2 -2 -2 -3 -3 -2 -2 -2 -2 -2 -1 -0
Change (%) 112.61 61.02 38.51 10.26 12.35 10.94 9.59 8.20 3.23 -8.96 -2.23 -12.39 -11.20 -14.95 -30.43
% of Revenue -0.36 -0.71 -1.03 -1.32 -1.36 -1.41 -1.46 -1.54 -1.57 -1.60 -1.38 -1.29 -1.07 -0.92 -0.79 -0.54 -0.07
Net Income 19 20 15 10 3 1 -2 -2 3 -2 -6 -14 -12 -12 -18 -10 -6 -11 -6
Change (%) 4.85 -26.73 -34.34 -68.82 -69.54 -351.40 -10.52 -223.14 -192.93 158.31 131.34 -15.08 -5.25 52.53 -42.13 -40.75 86.93 -43.11
% of Revenue 20.91 20.53 13.51 8.18 2.39 0.67 -1.57 -1.35 1.57 -1.44 -3.52 -7.81 -6.29 -5.73 -8.88 -5.05 -3.00 -5.71 -3.27

Source: Capital IQ

Other Listings
DE:8EQ € 3.26
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista